Search results
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance Canada· 3 days agoEli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks...Therefore, you...
If You Invested $1000 in Eli Lilly a Decade Ago, This is How Much It'd Be Worth Now
Zacks via Yahoo Finance Canada· 3 days agoFor most investors, how much a stock's price changes over time is important. Not only can...but it...
Eli Lilly (LLY) Beats Stock Market Upswing: What Investors Need to Know
Zacks via Yahoo Finance Canada· 2 days agoThe stock outperformed the S&P 500, which registered a daily gain of 0.07%. Meanwhile, the Dow...
Eli Lilly (LLY) to Buy Morphic for $3.2B, Boost IBD Presence
Zacks via Yahoo Finance Canada· 2 days agoEli Lilly's (LLY) acquisition of Morphic (MORF) is set to expand its immunology pipeline by adding...
Lilly beefs up bowel disease drug portfolio with $3.2 billion Morphic deal
AOL· 3 days ago(Reuters) -Eli Lilly agreed to buy Morphic Holding for $3.2 billion in cash, the companies said on Monday, beefing up its portfolio of inflammatory bowel ...
Here's Why Eli Lilly (LLY) is a Strong Momentum Stock
Zacks via Yahoo Finance Canada· 3 days agoEmploying factors like one-week price change and the monthly percentage change in earnings...
Eli Lily To Buy Morphic Holding For $3.2 Billion
Baystreet· 3 days ago(LLY) has announced that it is buying biopharmaceutical company Morphic Holding (MORF) for $3.2 billion U.S. Under terms of the deal, Eli Lilly ...
Eli Lilly to Buy Morphic for $3.2 Billion. Morphic Stock Nearly Doubles.
Barrons.com· 3 days agoLilly has agreed to pay $57 a share for Morphic or a 79% premium to the stock’s closing price of...
Eli Lilly awaits head-to-head study on GLP-1s after new report reaffirms superiority
Yahoo Finance· 2 days ago"Novo Nordisk...particular that the study looked at the diabetes drugs of each company, Ozempic for...
Pfizer’s Weight-Loss Pill is Back. It’s Too Little, Too Late.
Barrons.com· 4 hours agoBy then, Lilly could be launching orfoglipron, its experimental weight-loss pill, and other...